The Latin America, Middle East and Africa Probiotics Dietary Supplements Market is expected to witness market growth of 8.8% CAGR during the forecast period (2021-2027).
Probiotic products are used with an aim to detect mental diseases, and for the treatment of digestive problems and neurological diseases. In addition, they also support the human immune system, safeguard proteins & lipids from oxidative destruction, and decrease body pathogens. Additionally, the presence of probiotic ingredients in tablets, gel, capsules, and powders makes them highly popular among consumers.
The knowledge about health-giving ingredients and products has been increased in the region due to the high internet penetration. With this, consumers have become more concerned to adopt probiotic supplements in response to the unbalanced diet and lifestyle which lead to different medical ailments. In recent years, the key market players have been focused on increasing the availability of these products even to rural areas due to the greater need for healthy products among the rural population. Moreover, the rise in young population in the countries like Brazil and Argentina prefer the consumption of healthy beverages.
The Brazil market dominated the LAMEA Probiotics Dietary Supplements Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $210.5 million by 2027. The Argentina market is posed to grow at a CAGR of 9.7% during (2021 - 2027). Additionally, The UAE market is expected to showcase a CAGR of 8.2% during (2021 - 2027).
Based on Form, the Probiotics Dietary Supplements market is segmented into Capsules, Chewables & Gummies, Powders, Tablets & Softgels, and Others. Based on End User, the market is segmented into Adults, Geriatric, Children, and Infants. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., DuPont de Nemours, Inc., Chr. Hansen holding A/S, Archer Daniels Midland Company, Probi AB, BioGaia AB, Vitakem Nutraceutical, Inc., and ProbioFerm.
Scope of the Study
Market Segments Covered in the Report:
By Form
- Capsules
- Chewables & Gummies
- Powders
- Tablets & Softgels
- and Others
By End User
- Adults
- Geriatric
- Children
- Infants
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Chr. Hansen holding A/S
- Archer Daniels Midland Company
- Probi AB
- BioGaia AB
- Vitakem Nutraceutical, Inc.
- ProbioFerm
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Koninklijke DSM N.V.
- DuPont de Nemours, Inc.
- Chr. Hansen holding A/S
- Archer Daniels Midland Company
- Probi AB
- BioGaia AB
- Vitakem Nutraceutical, Inc.
- ProbioFerm
Methodology
LOADING...
